Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,285 | 503 | 78.4% |
| Consulting Fee | $1,995 | 5 | 16.8% |
| Education | $361.33 | 7 | 3.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,179 | 189 | $0 (2024) |
| Olympus Corporation | $1,995 | 5 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,327 | 89 | $0 (2024) |
| Janssen Biotech, Inc. | $839.59 | 37 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $558.62 | 36 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $464.71 | 19 | $0 (2024) |
| PFIZER INC. | $368.47 | 19 | $0 (2021) |
| QOL Medical, LLC | $313.55 | 17 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $248.93 | 2 | $0 (2022) |
| Gilead Sciences, Inc. | $235.07 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,931 | 100 | ABBVIE INC. ($795.83) |
| 2023 | $2,599 | 78 | Olympus Corporation ($1,155) |
| 2022 | $2,149 | 72 | Olympus Corporation ($840.00) |
| 2021 | $1,312 | 70 | Janssen Biotech, Inc. ($324.54) |
| 2020 | $677.25 | 36 | AbbVie Inc. ($216.45) |
| 2019 | $1,018 | 51 | AbbVie, Inc. ($235.33) |
| 2018 | $1,325 | 62 | AbbVie, Inc. ($274.05) |
| 2017 | $829.98 | 47 | AbbVie, Inc. ($312.04) |
All Payment Transactions
516 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Rare Disease | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $94.42 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Rare Disease | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $87.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.40 | General |
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $57.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,189 | 44,056 | $3.6M | $804,641 |
| 2022 | 34 | 2,025 | 3,767 | $1.0M | $252,701 |
| 2021 | 26 | 1,857 | 3,369 | $933,932 | $208,663 |
| 2020 | 27 | 1,749 | 2,875 | $867,665 | $185,994 |
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 13 | 18,000 | $1.2M | $312,289 | 26.7% |
| J1306 | Injection, inclisiran, 1 mg | Office | 2023 | 39 | 19,312 | $869,040 | $179,069 | 20.6% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 11 | 3,390 | $386,460 | $89,199 | 23.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 258 | 258 | $296,700 | $49,514 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 262 | $36,680 | $22,807 | 62.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 371 | 901 | $135,150 | $21,841 | 16.2% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 162 | 375 | $56,250 | $18,553 | 33.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 185 | 191 | $148,980 | $16,552 | 11.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 72 | 72 | $57,600 | $12,704 | 22.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 156 | 206 | $36,050 | $12,538 | 34.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 67 | 107 | $10,700 | $6,631 | 62.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $12,685 | $6,525 | 51.4% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 16 | 28 | $21,000 | $5,246 | 25.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 55 | $55,000 | $5,188 | 9.4% |
| 91120 | Test for tone and sensation of rectum and anus | Office | 2023 | 15 | 15 | $15,900 | $5,165 | 32.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 90 | $5,518 | $3,997 | 72.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 23 | 23 | $18,400 | $3,945 | 21.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 29 | 29 | $23,200 | $3,718 | 16.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 42 | 42 | $37,800 | $3,495 | 9.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 34 | $6,120 | $3,470 | 56.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 19 | 68 | $34,000 | $3,161 | 9.3% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 15 | 15 | $9,450 | $3,039 | 32.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 81 | $3,734 | $2,727 | 73.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 34 | $3,230 | $1,999 | 61.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 15 | 17 | $14,110 | $1,827 | 12.9% |
About Dr. Jacque Noel, MD
Dr. Jacque Noel, MD is a Gastroenterology healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558371450.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacque Noel, MD has received a total of $11,841 in payments from pharmaceutical and medical device companies, with $1,931 received in 2024. These payments were reported across 516 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($9,285).
As a Medicare-enrolled provider, Noel has provided services to 7,820 Medicare beneficiaries, totaling 54,067 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Lafayette, LA
- Active Since 08/09/2006
- Last Updated 08/01/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558371450
Products in Payments
- STELARA (Biological) $963.02
- ENTYVIO (Biological) $932.86
- Humira (Biological) $814.88
- RINVOQ (Biological) $704.69
- SKYRIZI (Biological) $692.77
- OCALIVA (Drug) $464.71
- HUMIRA (Biological) $456.12
- XELJANZ (Drug) $368.47
- CREON (Drug) $360.18
- XIFAXAN (Drug) $302.72
- TRULANCE (Drug) $245.31
- SUCRAID (Drug) $187.03
- IDACIO (Biological) $180.34
- Amitiza (Drug) $176.09
- VIBERZI (Drug) $158.04
- GI Genius (Device) $145.33
- LINZESS (Drug) $139.69
- Sucraid (Drug) $126.52
- Cimzia (Drug) $123.67
- Epclusa (Drug) $121.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lafayette
Dr. Kerri Glassner, D.o, D.O
Gastroenterology — Payments: $75,707
Dr. Jacob Karr, Md, MD
Gastroenterology — Payments: $42,466
Dr. Ramu Raju, Md, MD
Gastroenterology — Payments: $11,609
Dr. Stephen Abshire, Md, MD
Gastroenterology — Payments: $8,695
Jacob Breaux, M.d, M.D
Gastroenterology — Payments: $8,611
Erick Salvatierra, Md, MD
Gastroenterology — Payments: $4,439